Elekta announced today that its Evo CT linear accelerator (linac) received FDA 510(k) clearance, making it available to U.S. radiation oncology professionals.
SEATTLE, Jan. 15, 2026 /PRNewswire/ — Proprio, the surgical technology company pioneering real-time, AI-powered intraoperative guidance and data-driven surgical workflows, today announced the U.S. Food and Drug Administration (FDA) has granted clearance for the “Picasso” feature. This marks the company’s fourth FDA-cleared capability within its Paradigm platform.
AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG system.
A “unique” AI-powered headset that can predict epileptic seizures minutes before they occur has been developed by scientists in Scotland.
SAN JUAN, Puerto Rico, Jan. 7, 2026 /PRNewswire/ — CorePlus announced the implementation of AIxURO, a state-of-the-art software solution that utilizes artificial intelligence to significantly improve the accuracy and efficiency of bladder cancer detection. This innovative platform enhances traditional urine cytology analysis, providing faster, more precise diagnostics.
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
A study published in the journal eBioMedicine assesses the effectiveness of electrocardiograms (ECGs) analyzed via deep learning as a tool for early COPD detection.
A poor night’s sleep portends a bleary-eyed next day, but it could also hint at diseases that will strike years down the road. A new artificial intelligence model developed by Stanford Medicine researchers and their colleagues can use physiological recordings from one night’s sleep to predict a person’s risk of developing more than 100 health conditions.
Professor Jung Kyoon Choi’s research team from the Department of Bio and Brain Engineering, in collaboration with Neogen Logic Co., Ltd., developed the new AI model to predict neoantigens.
SEATTLE, Jan. 2, 2026 /PRNewswire/ — BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Intellidrop.